Net Income Summary of Bioqual, Inc.

Bioqual, Inc.'s latest annual net income in 2023 was 483.48 Thousand USD , down -42.14% from previous year.
Bioqual, Inc.'s latest quarterly net income in 2024 Q1 was -675.32 Thousand USD , up 42.56% from previous quarter.
Bioqual, Inc. reported an annual net income of 835.54 Thousand USD in 2022, down -84.12% from previous year.
Bioqual, Inc. reported an annual net income of 5.26 Million USD in 2021, down -16.85% from previous year.
Bioqual, Inc. reported a quarterly net income of -1.17 Million USD for 2023 Q4, down -527.48% from previous quarter.
Bioqual, Inc. reported a quarterly net income of 275.02 Thousand USD for 2023 Q3, down -43.25% from previous quarter.

Annual Net Income Chart of Bioqual, Inc. (2023 - 1995)

Historical Annual Net Income of Bioqual, Inc. (2023 - 1995)

Year	Net Income	Net Income Growth
2023	483.48 Thousand USD	-42.14%
2022	835.54 Thousand USD	-84.12%
2021	5.26 Million USD	-16.85%
2020	6.32 Million USD	49.54%
2019	4.23 Million USD	49.46%
2018	2.83 Million USD	-22.7%
2017	3.66 Million USD	-7.6%
2016	3.96 Million USD	37.69%
2015	2.87 Million USD	50.98%
2014	1.9 Million USD	119.58%
2013	868.2 Thousand USD	1095.14%
2012	-87.24 Thousand USD	0.0%
2010	401.66 Thousand USD	-3.54%
2009	416.41 Thousand USD	0.0%
2006	1.07 Million USD	37.45%
2005	782.83 Thousand USD	-0.28%
2004	785.01 Thousand USD	14.6%
2003	685.02 Thousand USD	29.43%
2002	529.26 Thousand USD	0.0%
2000	285.1 Thousand USD	193.18%
1999	97.24 Thousand USD	-75.37%
1998	394.88 Thousand USD	364.36%
1997	-149.37 Thousand USD	-3379.41%
1996	4555.00 USD	-95.06%
1995	92.19 Thousand USD	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-675.32 Thousand USD	42.56%
2023 Q4	-1.17 Million USD	-527.48%
2023 Q3	275.02 Thousand USD	-43.25%
2023 Q1	899.48 Thousand USD	228.1%
2023 Q2	484.66 Thousand USD	-46.12%
2022 Q3	-1.13 Million USD	-188.09%
2022 Q2	1.29 Million USD	-6.49%
2022 Q1	1.38 Million USD	-26.7%
2022 FY	835.54 Thousand USD	-84.12%
2022 Q4	-702.14 Thousand USD	38.39%
2021 Q4	1.88 Million USD	120.35%
2021 FY	5.26 Million USD	-16.85%
2021 Q3	856.58 Thousand USD	-24.82%
2021 Q1	1.37 Million USD	-35.13%
2021 Q2	1.13 Million USD	-17.25%
2020 Q1	1.76 Million USD	36.5%
2020 Q3	975.96 Thousand USD	-33.22%
2020 Q4	2.12 Million USD	117.52%
2020 FY	6.32 Million USD	49.54%
2020 Q2	1.46 Million USD	-17.27%
2019 FY	4.23 Million USD	49.46%
2019 Q3	720.4 Thousand USD	-19.22%
2019 Q1	1.32 Million USD	13.87%
2019 Q4	1.29 Million USD	79.65%
2019 Q2	891.84 Thousand USD	-32.66%
2018 Q3	465.77 Thousand USD	-18.9%
2018 Q1	627.67 Thousand USD	-53.47%
2018 FY	2.83 Million USD	-22.7%
2018 Q4	1.16 Million USD	149.72%
2018 Q2	574.31 Thousand USD	-8.5%
2017 Q3	799.01 Thousand USD	9.87%
2017 FY	3.66 Million USD	-7.6%
2017 Q1	786.69 Thousand USD	-28.81%
2017 Q2	727.26 Thousand USD	-7.55%
2017 Q4	1.34 Million USD	68.84%
2016 Q1	999.18 Thousand USD	-29.25%
2016 FY	3.96 Million USD	37.69%
2016 Q3	842.78 Thousand USD	-17.06%
2016 Q4	1.1 Million USD	31.11%
2016 Q2	1.01 Million USD	1.7%
2015 FY	2.87 Million USD	50.98%
2015 Q4	1.41 Million USD	118.15%
2015 Q3	647.39 Thousand USD	-6.26%
2015 Q2	690.61 Thousand USD	202.93%
2015 Q1	227.98 Thousand USD	-62.87%
2014 Q4	613.97 Thousand USD	103.62%
2014 FY	1.9 Million USD	119.58%
2014 Q1	439.18 Thousand USD	45.47%
2014 Q2	551.73 Thousand USD	25.63%
2014 Q3	301.53 Thousand USD	-45.35%
2013 FY	868.2 Thousand USD	1095.14%
2013 Q4	301.9 Thousand USD	60.31%
2013 Q2	206.05 Thousand USD	19.84%
2013 Q3	188.32 Thousand USD	-8.6%
2013 Q1	171.93 Thousand USD	310.73%
2012 Q3	-280.64 Thousand USD	-162.4%
2012 Q4	41.86 Thousand USD	114.92%
2012 Q2	-106.95 Thousand USD	0.0%
2012 FY	-87.24 Thousand USD	0.0%
2011 Q1	271.17 Thousand USD	21.53%
2010 FY	401.66 Thousand USD	-3.54%
2010 Q4	223.13 Thousand USD	169.93%
2010 Q3	82.66 Thousand USD	-22.69%
2010 Q1	-10.44 Thousand USD	-110.15%
2010 Q2	106.92 Thousand USD	1124.22%
2009 FY	416.41 Thousand USD	0.0%
2009 Q4	102.82 Thousand USD	-19.16%
2009 Q3	127.2 Thousand USD	213.0%
2009 Q2	40.64 Thousand USD	0.0%
2006 Q3	351.71 Thousand USD	49.49%
2006 Q4	108.39 Thousand USD	-69.18%
2006 Q2	235.27 Thousand USD	-38.18%
2006 Q1	380.58 Thousand USD	335.92%
2006 FY	1.07 Million USD	37.45%
2005 Q3	261.42 Thousand USD	133.33%
2005 Q2	112.04 Thousand USD	-65.21%
2005 FY	782.83 Thousand USD	-0.28%
2005 Q1	322.05 Thousand USD	0.0%
2005 Q4	87.3 Thousand USD	-66.6%
2004 FY	785.01 Thousand USD	14.6%
2003 FY	685.02 Thousand USD	29.43%
2002 FY	529.26 Thousand USD	0.0%
2001 Q1	95.72 Thousand USD	-18.94%
2001 Q2	74.32 Thousand USD	-22.35%
2001 Q3	87.53 Thousand USD	17.76%
2000 Q4	118.09 Thousand USD	148.3%
2000 FY	285.1 Thousand USD	193.18%
2000 Q3	47.56 Thousand USD	-33.99%
2000 Q2	72.05 Thousand USD	52.0%
2000 Q1	47.4 Thousand USD	-8.47%
1999 FY	97.24 Thousand USD	-75.37%
1999 Q4	51.79 Thousand USD	410.11%
1999 Q2	24.3 Thousand USD	0.0%
1999 Q3	10.15 Thousand USD	-58.22%
1998 FY	394.88 Thousand USD	364.36%
1997 FY	-149.37 Thousand USD	-3379.41%
1996 FY	4555.00 USD	-95.06%
1995 FY	92.19 Thousand USD	0.0%

Peer Net Income Comparison of Bioqual, Inc.

Name	Net Income	Net Income Difference
American Bio Medica Corporation	-1.41 Million USD	134.289%
Arrayit Corporation	-3.31 Million USD	114.582%
Atlantic International Corp.	-5.62 Million USD	108.591%
Biocept, Inc.	-32.08 Million USD	101.507%
CardioGenics Holdings Inc	-1.91 Million USD	125.23%
DermTech, Inc.	-100.88 Million USD	100.479%
Global WholeHealth Partners Corporation	- USD	-Infinity%
Hangzhou Tigermed Consulting Co., Ltd.	2.02 Billion USD	99.976%
HTG Molecular Diagnostics, Inc.	-21.59 Million USD	102.239%
iMD Companies, Inc.	-200.63 Thousand USD	340.974%
IDenta Corp.	14.64 Thousand USD	-3201.564%
Interpace Biosciences, Inc.	802 Thousand USD	39.716%
Integrative Health Technologies, Inc.	38.68 Thousand USD	-1149.66%
InVitro International	1553.00 USD	-31032.067%
Lumos Diagnostics Holdings Limited	-8.59 Million USD	105.627%
Many Bright Ideas Technologies Inc.	-58.11 Thousand USD	931.981%
Medical Imaging Corp.	-3.02 Million USD	115.993%
NovelStem International Corp.	-4.18 Million USD	111.546%
Optigenex Inc.	-2.89 Million USD	116.685%
PharmChem, Inc.	845.1 Thousand USD	42.79%
Proteome Sciences plc	-2.44 Million USD	119.79%
Response Genetics, Inc	-20.18 Million USD	102.395%
Rennova Health, Inc.	-3.29 Million USD	114.682%
RushNet, Inc.	-607.02 Thousand USD	179.647%
ScreenPro Security Inc.	-2.24 Million USD	121.5%
Stella Diagnostics Inc.	-5.7 Million USD	108.471%
StageZero Life Sciences Ltd.	-11.41 Million USD	104.235%
Todos Medical Ltd.	-24.99 Million USD	101.934%

Global Stocks Search

Bioqual, Inc. (BIOQ)

Net Income Summary of Bioqual, Inc.

Annual Net Income Chart of Bioqual, Inc. (2023 - 1995)

Historical Annual Net Income of Bioqual, Inc. (2023 - 1995)

Peer Net Income Comparison of Bioqual, Inc.